DK2646036T3 - Topiske sammensætninger til bevarelse eller gendannelse af integriteten af slimhinder - Google Patents

Topiske sammensætninger til bevarelse eller gendannelse af integriteten af slimhinder

Info

Publication number
DK2646036T3
DK2646036T3 DK11805602.7T DK11805602T DK2646036T3 DK 2646036 T3 DK2646036 T3 DK 2646036T3 DK 11805602 T DK11805602 T DK 11805602T DK 2646036 T3 DK2646036 T3 DK 2646036T3
Authority
DK
Denmark
Prior art keywords
preserving
restoring
integrity
mucous membranes
topical compositions
Prior art date
Application number
DK11805602.7T
Other languages
English (en)
Inventor
Schiena Michele Giuseppe Di
Original Assignee
Ricerfarma Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ricerfarma Srl filed Critical Ricerfarma Srl
Application granted granted Critical
Publication of DK2646036T3 publication Critical patent/DK2646036T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK11805602.7T 2010-11-30 2011-11-29 Topiske sammensætninger til bevarelse eller gendannelse af integriteten af slimhinder DK2646036T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2010A002218A IT1402907B1 (it) 2010-11-30 2010-11-30 Composizioni topiche per mantenere o ripristinare l'integrita' delle mucose.
PCT/IB2011/055364 WO2012073191A1 (en) 2010-11-30 2011-11-29 Topical compositions for preserving or restoring the integrity of mucosae

Publications (1)

Publication Number Publication Date
DK2646036T3 true DK2646036T3 (da) 2014-10-06

Family

ID=43742830

Family Applications (1)

Application Number Title Priority Date Filing Date
DK11805602.7T DK2646036T3 (da) 2010-11-30 2011-11-29 Topiske sammensætninger til bevarelse eller gendannelse af integriteten af slimhinder

Country Status (22)

Country Link
US (1) US9050351B2 (da)
EP (1) EP2646036B1 (da)
JP (1) JP5847833B2 (da)
KR (1) KR101845472B1 (da)
CN (1) CN103313716B (da)
AU (1) AU2011336166B2 (da)
BR (1) BR112013013351B1 (da)
CA (1) CA2819307C (da)
CY (1) CY1115708T1 (da)
DK (1) DK2646036T3 (da)
ES (1) ES2521065T3 (da)
HR (1) HRP20141099T1 (da)
IL (1) IL226638A (da)
IT (1) IT1402907B1 (da)
MX (1) MX337437B (da)
PL (1) PL2646036T3 (da)
PT (1) PT2646036E (da)
RS (1) RS53598B1 (da)
RU (1) RU2013125021A (da)
SI (1) SI2646036T1 (da)
WO (1) WO2012073191A1 (da)
ZA (1) ZA201303910B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102940724A (zh) * 2012-08-16 2013-02-27 江西普正制药有限公司 一种用于消炎的中药复方胶囊的制备方法
ITMI20131219A1 (it) * 2013-07-19 2015-01-20 Ricerfarma Srl Colina alfoscerato come inibitore di ialuronidasi
RU2551312C1 (ru) * 2014-04-24 2015-05-20 Людмила Владимировна Уварова Способ восстановления тканей зубочелюстной системы
KR101853347B1 (ko) * 2014-08-29 2018-04-30 주식회사유한양행 콜린 알포세레이트-함유 정제 및 이의 제조방법
RS60926B1 (sr) * 2015-03-26 2020-11-30 Dmg Italia Srl Oftalmološka kompozicija za zaštitu rožnjače
CZ28634U1 (cs) 2015-05-05 2015-09-14 Contipro Pharma A.S. Dentální přípravek na bázi hyaluronanu a oktenidin dihydrochloridu
RU2632718C2 (ru) * 2015-12-25 2017-10-09 Общество с ограниченной ответственностью "Фармамед" Спрей для орального применения, содержащий холина альфосцерат.
KR101744538B1 (ko) * 2017-03-17 2017-06-09 주식회사 대웅제약 콜린 알포세레이트를 함유하는 수성 액상 제제
IT201700048750A1 (it) * 2017-05-05 2018-11-05 Farm Procemsa S P A Composizione per il trattamento di afte e ulcere buccali
RU2684118C2 (ru) * 2017-09-27 2019-04-04 Общество с ограниченной ответственностью "Фармамед" Спрей для орального применения, содержащий холина альфосцерат
KR101864384B1 (ko) * 2017-12-11 2018-06-04 (주)나노스템 콜린 알포세레이트를 유효성분으로 하는 쥐남의 치료, 개선 또는 예방용 조성물 및 방법
WO2019208898A1 (ko) * 2018-04-24 2019-10-31 한국유나이티드제약 주식회사 콜린알포세레이트를 함유하는 액상 시럽제제
CN108452291A (zh) * 2018-07-04 2018-08-28 西南大学 用天然丝胶蛋白治疗溃疡性结肠炎的方法
EP3982913A1 (en) * 2019-06-14 2022-04-20 The Procter & Gamble Company Leave-on oral care compositions
EP3982912A1 (en) * 2019-06-14 2022-04-20 The Procter & Gamble Company Leave-on oral care compositions
WO2020248239A1 (en) 2019-06-14 2020-12-17 The Procter & Gamble Company Leave-on oral care compositions
CN113950319A (zh) 2019-06-14 2022-01-18 宝洁公司 免洗型口腔护理组合物
IT202000004069A1 (it) * 2020-02-27 2021-08-27 Ricerfarma Srl Composizioni topiche per il mantenimento e/o ripristino dell’integrità delle mucose e dell’epidermide lesa
IT202000022042A1 (it) 2020-09-18 2022-03-18 Ricerfarma Srl Composizioni topiche antivirali comprendenti acido ialuronico e carragenina
KR102728573B1 (ko) * 2020-11-03 2024-11-08 주식회사 아폴로니아 치약용 조성물
IT202300019392A1 (it) * 2023-09-21 2025-03-21 Inpha Res S R L Composizione solida sublinguale a base di glutatione ed almeno una vitamina
IT202400003238A1 (it) * 2024-02-15 2025-08-15 Ricerfarma Srl Compressa orale mucoadesiva per il trattamento sintomatico della xerostomia, delle afte e delle infiammazioni del cavo orale

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1240316B (it) * 1990-02-21 1993-12-07 Ricerca Di Schiena Del Dr. Michele G. Di Schiema & C. Composizioni a base di acido ialuronico ad alto peso molecolare somministrabili per via topica per il trattamento di infiammazioni del cavo orale ,per la cosmetica e l'igiene del cavo orale
CH683671A5 (it) * 1992-03-30 1994-04-29 Golgi Sa Uso topico di glicerofosfolipidi deacilati.
JPH06107550A (ja) * 1992-09-29 1994-04-19 Yutaka Kurachi 経口抗炎症剤
US20020049422A1 (en) * 1994-03-31 2002-04-25 Brewitt Barbara A. Homeopathic preparations
AU3327000A (en) * 1999-03-24 2000-10-09 Seikagaku Corporation Artificial saliva
US7354910B2 (en) * 2001-10-18 2008-04-08 Seikagaku Kogyo Kabushiki Kaisha Agent for treating inflammatory bowel diseases
US20060014813A1 (en) * 2003-11-26 2006-01-19 Patrick Connelly Pharmaceutical compounds that regenerate in vivo
US20050143343A1 (en) * 2003-12-30 2005-06-30 Nerenberg Arnold P. Nutritional supplement for enhancing the production and effect of natural human growth hormone
ITMI20061932A1 (it) * 2006-10-09 2008-04-10 Carlo Ghisalberti Complessi a trasferimento di carica per uso medicale
JP5198899B2 (ja) * 2008-02-28 2013-05-15 株式会社コーセー 細胞賦活剤及び老化防止用皮膚外用剤
JP2009155337A (ja) * 2009-03-31 2009-07-16 Tsujido Chemical Corp 治療剤

Also Published As

Publication number Publication date
CN103313716B (zh) 2016-06-01
AU2011336166A1 (en) 2013-06-20
MX2013006045A (es) 2013-10-25
RS53598B1 (sr) 2015-02-27
PL2646036T3 (pl) 2015-02-27
EP2646036B1 (en) 2014-08-27
ES2521065T3 (es) 2014-11-12
CN103313716A (zh) 2013-09-18
KR20140020838A (ko) 2014-02-19
ZA201303910B (en) 2014-07-30
IL226638A (en) 2016-08-31
JP2014501733A (ja) 2014-01-23
WO2012073191A1 (en) 2012-06-07
RU2013125021A (ru) 2014-12-10
MX337437B (es) 2016-03-03
US20120135087A1 (en) 2012-05-31
US9050351B2 (en) 2015-06-09
CA2819307A1 (en) 2012-06-07
JP5847833B2 (ja) 2016-01-27
ITMI20102218A1 (it) 2012-05-31
BR112013013351A2 (pt) 2016-09-13
PT2646036E (pt) 2014-11-03
BR112013013351B1 (pt) 2019-09-03
HK1185008A1 (zh) 2014-02-07
KR101845472B1 (ko) 2018-04-04
SI2646036T1 (sl) 2014-12-31
HRP20141099T1 (hr) 2014-12-19
IT1402907B1 (it) 2013-09-27
CY1115708T1 (el) 2017-01-25
CA2819307C (en) 2018-08-14
EP2646036A1 (en) 2013-10-09
AU2011336166B2 (en) 2016-03-24

Similar Documents

Publication Publication Date Title
ZA201303910B (en) Topical compositions for preserving or restoring the integrity of mucosae
CO6970594A2 (es) Composiciones hemostáticas
EP3741486C0 (en) BLADE GUARD ASSEMBLY
DK3513803T3 (da) Hæmostatiske sammensætninger
DK3520805T3 (da) Sammensætninger til behandling af myelofibrose
LT3091029T (lt) Anti-il13 antikūno kompozicijos
PL2793600T3 (pl) Topliwa bezdymna kompozycja tytoniowa
DK3372228T3 (da) Ikke-terapeutisk fremgangsmåde til at øge eller opretholde mitokondriefunktion
PT2621277T (pt) Composições fungicidas
BR112012031667A2 (pt) composição
DK3050972T3 (da) Fremgangsmåder til fremstilling af eicosapentaensyre i thraustochytrider
EP2790508A4 (en) FUNGICIDE COMPOSITIONS
LT3246021T (lt) Apiksabano kompozicijos
DK2790675T3 (da) Anvendelse af polymerexcipienser til frysetørring eller frysning af partikler
CO6990720A2 (es) Composiciones que comprenden galatos y galamidas
DK2533761T3 (da) Fremgangsmåder og sammensætninger til fremstilling af aerosoler
BR112012032683A2 (pt) composição
SI3138916T1 (sl) Imunogeni sestavek
EP2786976A4 (en) MONOLITHIC COMPOSITION
DK2588620T3 (da) Fremgangsmåde til fremstilling af butanol eller acetone
EP2628769A4 (en) FILM FORMING COMPOSITION
BR112012032980A2 (pt) composição
EP2635269A4 (en) COMBINATION COMPOSITION
DK2950822T3 (da) Farmaceutisk sammensætning til beskyttelse af sår, tilvejebringelse af hæmostase eller forebyggelse af adhæsion i mave-tarm-kanalen
DK2646011T3 (da) Fremgangsmåder til reduktion af overspisning eller tvangsspisning